Clinical trial Recruiting at 1 site Observational Ages 18 and up

Photon-counting CT with intracoronary imaging for detailed coronary plaque characterization

Official title: Coronary Evaluation And Guided Lesion Exploration Using Photon-counting CT and Intracoronary Imaging Techniques

Run by Universitaire Ziekenhuizen KU Leuven · NCT07036770 · Data updated 2026-11-12

This will test whether ultra–high-resolution photon-counting CT can reliably characterize coronary plaque compared with OCT and IVUS in adults with acute or chronic coronary syndrome, including patients with suspected in-stent restenosis or prior PCI for chronic total occlusion.

More Coronary Artery Disease trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment100 (estimated)
SponsorUniversitaire Ziekenhuizen KU Leuven
Academic / other
Locations1 site (Leuven)
StatusRecruiting
StartedJune 16, 2025
Main results expectedMay 31, 2027
Study endsMay 31, 2027
Registry record updatedJune 25, 2025
Trial IDNCT07036770 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18 years) with suspected acute coronary syndrome (UA or NSTEMI) or chronic coronary syndrome who are stable enough for scheduled PCCT and invasive coronary angiography are ideal candidates.

Probably not a fit

Patients with STEMI, hemodynamic instability, unstable ventricular arrhythmias, Killip class III–IV heart failure, or severe renal impairment (creatinine clearance <30 ml/min/1.73 m2 unless on dialysis) are unlikely to benefit or be eligible for this protocol.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study will enroll 100 adults presenting with either acute (UA/NSTEMI) or chronic coronary syndrome and perform cardiac photon-counting CT shortly before clinically indicated invasive coronary angiography. During angiography, intracoronary imaging such as optical coherence tomography (OCT) and intravascular ultrasound (IVUS) will be acquired as reference standards for plaque morphology. The primary goal is to determine the diagnostic accuracy and limitations of photon-counting CT for plaque characterization and to compare its findings to OCT/IVUS. The cohort includes targeted subgroups (40 with suspected in-stent restenosis and 10 one year post-PCI for CTO) to examine performance in common clinical scenarios.

Why it matters

Potential benefit: If successful, photon-counting CT could provide accurate, non-invasive plaque characterization that helps guide treatment decisions and may reduce reliance on invasive intracoronary imaging.

How similar studies have gone: Photon-counting CT is an emerging technology with promising early data on improved spatial resolution and soft-tissue contrast, but direct head-to-head comparisons with intracoronary OCT/IVUS for coronary plaque characterization remain limited.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion criteria:

Participants eligible for inclusion in this study must meet all of the following criteria:

1. Voluntary written informed consent of the participant or their legally authorized representative has been obtained prior to any screening procedures.
2. At least 18 years of age at the time of signing the Informed Consent Form (ICF).
3. Patients presenting with suspected acute coronary syndrome (UA or NSTEMI) or chronic coronary syndrome (stable angina or silent ischemia).

Exclusion criteria:

Participants eligible for this study must not meet any of the following criteria:

1. Patients presenting with STEMI.
2. Haemodynamically unstable patients.
3. Unstable ventricular arrhythmias.
4. Killip class III-IV heart failure.
5. Creatinine clearance \<30 ml/min/1.73 m2 (as calculated by CKD-EPI formula 2009 for estimated GFR) and not on dialysis. Note: patients dependent on long-term dialysis are eligible for enrolment irrespective of their creatinine clearance levels.
6. Severe coronary vessel tortuosity.
7. Subject has known hypersensitivity to radiocontrast dye or that cannot be adequately pre-medicated.
8. Female who is pregnant or breast-feeding.

Where it's running

  • UZ Leuven
    Leuven, Belgium
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.